Yakult Honsha Co., Ltd.

上海 2024年9月27日 /美通社/ -- 2024年9月24-25日，第四届马家浜健康食品创新发展活动在嘉兴隆重举行，来自养乐多本社中央研究所的天本隆太和织原健人研究员，分别就益生菌对于老年人健康的作用、以及 kashiwanohense 双歧杆菌的基因组和表型特征研究发表主题演讲，展示了养乐多在人群健康和益生菌研发领域的研究成果。 本次活动由浙江清华长三角研究院主办，汇聚了健康食品领域的权威专家学者，紧贴市场需求，围绕食品安全、营养强化、新食品原料开发、创新配方设计、食品企业转型升级以及新蛋白市场机遇等热点话题进行深入探讨和交流。 养乐多本社中央研究所天本隆太研究员发表主题演讲 聚焦前沿创新 强化循证科学实践 随着人们生活水平的提高，人均寿命的延长，全球的人口老龄化进程正在迅速发展。如何让每位老年人安度晚年，享有健康老年生活，已经成为全社会普遍关心的话题。本次活动上天本隆太以《老年人益生菌摄入频率与健康状况的关系：一项流行病学研究》为题，分享了副干酪乳酪杆菌代田株（LcS）对于老年人主要生活习惯病和肠道健康的影响。 高血压和便秘在世界各地的老年人中普遍存在，有效的预防和控制有助于改善老年人的健康状况。研究结果显示，老年人的高血压患病风险与含有LcS的发酵乳制品的摄入频率呈负相关。老年人排便次数稀少的发生风险与含有LcS的发酵乳制品的摄入频率以及习惯性运动活动的数量和质量呈负相关。 养乐多本社中央研究所织原健人研究员发表主题演讲 织原健人在食品新配方专场中聚焦于《 KASHIWANOHENSE 双歧杆菌的基因组和表型特征》进行演讲，详细阐述了 kashiwanohense 双歧杆菌的微生物系统发育位置、人群分布特征、碳水化合物的利用特性，以及低聚糖利用的主要基因。研究表明， kashiwanohense 双歧杆菌可以利用具有菌种特异性转运蛋白的短链和长链母乳低聚糖、阿拉伯木聚糖和胞外木聚糖酶，这些特征对断奶期婴儿有较好的适应性。织原健人表示，这些研究发现将为开发益生菌方向或益生元方向的新型食品提供参考，例如：具有年龄适应性的益生菌、定制益生元等。 以科研为先导 深耕益生菌领域 二十世纪初，养乐多集团创始人代田稔医学博士发现并强化培养出能够活着到达肠道的活性乳酸菌——副干酪乳酪杆菌代田株（LcS）。自创立以来，养乐多始终专注于乳酸菌的科学研究，致力于探索乳酸菌对人体健康的益处。 养乐多本社中央研究所 为持续进行产品健康性与功能性的创新开发，养乐多位于日本和欧洲的研究所开展了益生菌功能、肠道免疫学、肠道菌群、微生物群-肠-脑轴、微生物采集和功能分析等方面的基础研究，积累权威的科学循证，不断挖掘益生菌的健康价值。同时，养乐多与众多科研和医疗机构深入合作，共同开展LcS在调节肠道功能、调节免疫、预防感染、缓解精神压力等方面的研究，挖掘LcS的潜力。在中国，养乐多与国内的医院、大学、行业组织也进行了广泛合作。2023年7月在国际学术期刊《Food & Function》上正式发表了养乐多与上海交通大学附属瑞金医院进行了一项关于LcS对帕金森病临床症状和肠道菌群影响的研究。 秉承"预防医学、健肠长寿、轻松享有"的代田理念，养乐多不断探索生命科学，为世界人类的健康和美好生活作贡献，将深耕益生菌科研前沿，为人类的健康事业源源不断注入"益"动力。

NEW YORK, Jan. 7, 2024 /PRNewswire/ -- How is the Probiotics Market expected to grow in the next five years? Continue Reading Technavio has announced its latest market research report titled Global Probiotics Market 2024-2028 The probiotics market size is expected to grow by USD 32.06 billion from 2023 to 2028, according to Technavio. In addition, the growth momentum of the market will progress at a CAGR of 7.84% during the forecast period. The health benefits of probiotics are notably driving the probiotics market. However, factors such as the high prices of probiotic products in developing countries may impede market growth. The market is segmented by End-user (Human probiotics and Animal probiotics), Product (Probiotic functional food and beverage, Dietary supplements, and Animal feed), and Geography (APAC, Europe, North America, Middle East and Africa, and South America). Technavio provides a comprehensive report summary describing the market size and forecast along with research methodology. The sample report is available in PDF format Which segment is significantly contributing to the Probiotics Market? The human probiotics segment is expected to contribute significant market share during the forecast period. Due to increased health awareness, especially in countries like the US, the demand for probiotics in functional foods, beverages, and dietary supplements is rising. Probiotics deliver advantages such as enhancing the skin's moisture barrier, reducing oxidative stress, protecting against UV-induced damage, preserving pH levels, and improving hair quality. To know additional highlights and key points on various market segments and their impact in coming years, View a FREE PDF Sample Report. In which region the Probiotics Market is expected to grow in the next five years? APAC will contribute 37% to the growth of the global market during between 2023 - 2028. China is the first-largest probiotics market in APAC after Japan. The market in China is growing at a fast rate due to its high demand for various probiotic products, particularly yogurt and functional foods. Yakult makes a wide range of products, like fermented milk drinks and yogurts, and in other fields, including foods and beverages, cosmetics, and pharmaceuticals. Market Dynamics What are the main growth drivers for the Probiotics market? Product innovations drive the growth of the Probiotics Market, boosting advancements in Gut Health and Digestive Health. These innovations cater to Probiotic Supplements, enhancing Beneficial Bacteria and Microbiome Health in promoting Intestinal Flora balance. Diverse Probiotic Foods and unique Probiotic Strains improve wellness. Furthermore, the integration of Prebiotics in Fermented Foods supports Immune Support and fosters a balanced Gut Microbiota, improving the role of innovation in driving the market's expansion. What is the overall market trend for Probiotics? An influential trend in the Probiotics Market's growth is the expanding use of probiotics in the cosmetic industry. This trend harnesses Probiotic Research and explores diverse Probiotic Benefits, extending beyond Oral Probiotics and Probiotic Capsules. It reshapes markets like Women's Health Probiotics, boosting Probiotic Health Claims and utilizing unique Probiotic Cultures in innovative Probiotic Skin Care. Additionally, this trend embraces applications such as Infant Probiotics, Animal Probiotics, and incorporates Digestive Enzymes, driving market expansion and diversification. What are some of the challenges faced by the Probiotics Market? The Probiotics Market encounters a significant challenge in developing nations due to the elevated prices of probiotic products. This hurdle affects Probiotic Strain Diversity and hampers Probiotic Industry Trends, particularly in the Probiotic Supplements Market and Probiotic Drinks sectors. High prices restrict access to beneficial products like Probiotic Yogurt and hinder the utilization of Digestive Enzymes, impeding market growth and accessibility in these regions. Comprehensive Probiotic Market Analysis underscores this pricing obstacle affecting market expansion in developing countries. What is the nature of the Probiotics Market? The probiotics market is fragmented, and the companies are deploying organic and inorganic growth strategies to compete in the market. Who are the top companies operating in the probiotics market? The major companies operating in the probiotics market are: AnaBio Technologies, Archer Daniels Midland Co., BioGaia AB, Chr Hansen Holding AS, Danone SA, Dr. Willmar Schwabe GmbH and Co. KG, DuPont de Nemours Inc., Farmhouse Culture Inc., General Mills Inc., Kerry Group Plc, Lallemand Inc., Lifeway Foods Inc., Microbiome Labs UK Ltd., Nestle SA, Novozymes AS, PepsiCo Inc., Probulin Probiotics LLC, SANZYME BIOLOGICS PVT. LTD., SIG Group AG, Symrise AG, Thats it Nutrition LLC, Natures Bounty, Uncle Matts Organic, Yakult Honsha Co. Ltd. View a PDF Sample Report to find additional highlights on the growth strategies adopted by companies and their product offerings. Related Reports: The digestive health supplements market size is estimated to grow at a CAGR of 7.12% between 2022 and 2027. The market size is forecast to increase by USD 7.86 billion. The probiotic ingredients market share is expected to increase by USD 2.21 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.99%. ToC: Executive Summary Market Landscape Market Sizing Historic Market Sizes Five Forces Analysis Market Segmentation by End-user Market Segmentation by Product Market Segmentation by Geography Customer Landscape Geographic Landscape Drivers, Challenges, & Trends Company Landscape Company Analysis Appendix About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contacts Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 Email: [email protected] Website: SOURCE Technavio

上海 2023年11月9日 /美通社/ -- 10月27日，由养乐多生命科学基金会主办，日本文部科学省支持的第31届肠内菌群国际研讨会在日本成功举行，来自中国、日本、巴西、荷兰等多个国家的约400名专家学者及相关行业人员齐聚一堂，分享、探讨了国际肠内微生态领域的最新研究成果。同期还举办了围绕干酪乳杆菌代田株（ Lactobacillus casei strain Shirota，LcS）菌株探索的研讨会，来自上海交通大学医学院附属瑞金医院神经内科的杨晓东医学博士在研讨会上发表了题为"针对帕金森病患者便秘症状的有效性试验"的演讲，受到与会专家的积极提问和一致好评。 第31届肠内菌群国际研讨会 流行病语境下的肠道微生物群研究 在过去三年里，全球性传染病的流行影响了社会生活的方方面面，也激励着全球各地的专业人士以此为切入点，从多角度探索疾病的防治。本届肠内菌群国际研讨会围绕"肠内菌群与传染性疾病控制"这一主题，邀请了7位来自世界各地的专家发表了精彩演讲。 巴西南里奥格兰德天主教大学的Ana Paula Duarte de Souza教授介绍了肠道微生物群及其代谢物在病毒性呼吸道感染中的作用；日本国立国际医疗研究中心的河冈义裕教授发表了关于"应对新型病毒感染的威胁"的演讲；荷兰阿姆斯特丹大学医学中心的Vanessa Harris教授生动形象地介绍了肠道微生物群与轮状病毒疫苗疗效之间的关系：从相关到因果关系。 聚焦帕金森人群肠道菌群持续深入探索 随着肠道菌群研究的不断深入，近年来，特殊人群的肠胃状况及健康逐渐成为肠道菌群研讨关注的重要课题。上海交通大学医学院附属瑞金医院的杨晓东医学博士团队针对帕金森患者便秘症状开展了研究。帕金森病（Parkinson's disease，PD）是一种神经退行性疾病，随着年龄的增长，患上神经退行性疾病的机会也逐步增加，帕金森作为老年人常见的一种神经退行性疾病，临床表现包括运动症状和一系列非运动症状。运动症状包括震颤、肌强直和动作迟缓，而非运动症状除了便秘等肠道功能障碍，也包括比如认知障碍、自主神经功能障碍和睡眠障碍等。该研究就补充LcS对帕金森病患者临床症状、肠道菌群和粪便代谢物的影响进行了有效性试验。 干酪乳杆菌代田株（Lactobacillus casei strain Shirota，LcS） 研究共计招募了128位帕金森病患者，年龄在55-80岁之间，随机分为LcS干预组或安慰剂组，分别在每日早餐时服用LcS（100毫升，含1×10 10 个活性LcS的发酵乳）或安慰剂，持续12周。杨晓东医生表示，研究虽然没有发现肠道菌群或粪便代谢物的组成发生显著变化，但LcS干预后显著减轻了患者便秘相关症状及其他非运动症状。证实了LcS在治疗帕金森病患者便秘和其他非运动症状方面具有良好效果。另外，研究还发现与安慰剂组相比，LcS组的酪氨酸浓度在粪便中显著降低，但在血浆中则增加。酪氨酸是多巴胺的前体，而多巴胺是帕金森病患者所缺乏的大脑化学神经递质。这一研究的论文《补充干酪乳杆菌代田株对帕金森病临床症状及肠道菌群的影响》已于今年7月12日在《Food & Function》上正式发表。 二十世纪初，养乐多创始人代田稔医学博士发现并强化培养出能够活着到达肠道的活性乳酸菌——LcS。此后，为传承代田理念，养乐多集团不断开展有关LcS的各项研究，在日本与欧洲的两家养乐多研究所内的数百名研究人员，利用各种世界先进技术与设备，对菌群进行着高效率、高精度的分析，更清楚地了解肠内菌群与健康之间的关系，持续探索LcS的健康作用。 位于日本东京的养乐多本社中央研究所 在中国，养乐多与国内科研单位多次合作开展针对中国人群的LcS研究，在肠内存活性、免疫功能的影响等方向均取得了一定的成果并进行了发表，为展示益生菌的有效性提供了充分的科学论证。同时养乐多还积极支持青年科研人员的探索工作，与中国食品科学技术学会共同设立的肠道健康与益生菌青年科研基金，已通过专家评审确定了3个方向的课题，将为益生菌领域的发展提供更有力的循证基础。未来，养乐多也将不断探索生命科学并加以研究证明，为人类健康发展作出贡献。